HSA
HSA
Affibody® Research Reagent | Catalog number | Size | Price |
---|---|---|---|
Anti-HSA, unconjugated |
10.0644.01.0010 |
1 mg |
€ 715 |
Anti-HSA, unconjugated |
10.0644.01.0050 |
5 mg |
€ 2 495 |
Anti-HSA, biotin conjugated |
10.0644.02.0005 |
500 µg |
€ 715 |
Affibodys latest Press releases
2023-01-05
Positive Top-line Clinical Data for Izokibep in Hidradenitis Suppurativa
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)